Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Drug
Guangdong Zhongsheng Starts Phase III Trial for COVID-19 Drug RAY1216
January 31, 2025
Company
Drug
Yabao Receives FDA Clearance for Generic Nexavar
January 31, 2025
Company
Deals
Hansoh Pharmaceutical Licenses Biotheus’ Bispecific Antibody PM1080 for Greater China
January 31, 2025
Company
Deals
Sansure Biotech Partners with UBC to Manufacture in Indonesia
January 31, 2025
Company
HutchMed Shifts Focus to Late-Stage Pipeline for Regulatory Approvals
January 31, 2025
Company
Deals
Harbour BioMed and WuXi Biologics Announce Strategic Collaboration
January 31, 2025
Company
Drug
Hengrui’s Pyrotinib Granted Priority Review for HER2-Positive Breast Cancer
January 31, 2025
Policy / Regulatory
CDE Issues Guidelines for Bispecific Antibody Antitumor Drug Development
January 31, 2025
Company
Drug
AstraZeneca to Launch Soliris in Hangzhou After Regulatory Approval
January 31, 2025
Company
Drug
Akeso Biopharma’s AK112 Receives Two New Breakthrough Therapy Designations
January 31, 2025
Company
CStone Launches Patient Assistance Program for IDH1 Inhibitor Tibsovo
January 31, 2025
Company
Drug
HutchMed Announces Initial Results from FRUTIGA Phase III Study
January 31, 2025
1
2
…
1,093
1,094
1,095
1,096
1,097
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
